Literature DB >> 6092480

Angiotensin I conversion by human and rat chymotryptic proteinases.

B U Wintroub, N B Schechter, G S Lazarus, C E Kaempfer, L B Schwartz.   

Abstract

Human skin chymotrypsin-like proteinase, human neutrophil cathepsin G, rat mast cell chymase, and rat salivary gland tonin are cell-derived serine proteinases of similar size with specificity for amino acids of aromatic residues. Each enzyme was examined for its ability to convert angiotension I to angiotensin II and to cleave a panel of synthetic substrates. Skin chymotryptic proteinase, cathepsin G, and tonin cleaved the phe8-his9 bond of angiotensin I and converted angiotensin I to angiotensin II without further degradation. In contrast, chymase formed relatively small amounts of angiotensin II because it preferentially cleaved the tyr4-ile5 bond of angiotensin I. The rank order of angiotensin I converting activity was skin chymotryptic proteinase greater than tonin greater than cathepsin G greater than chymase. The Km and Kcat for angiotensin I conversion by the human skin enzyme were 6.6 X 10(-5) M and 50 s-1, respectively. The angiotensin I converting activity of human skin chymotryptic proteinase is equal to or greater than the peptidyl dicarboxypeptidase angiotensin-converting enzyme. Substrate specificities of each enzyme were further distinguished by use of benzoyl-L-tyrosine ethyl ester. A limited immunologic characterization of each enzyme was performed with monospecific goat antiserum to cathepsin G and chymase by Ochterlony gel diffusion. Each antiserum gave a precipitin line against its respective immunogen without evidence of cross-reactivity against the other enzymes. Human skin chymotryptic proteinase, cathepsin G, and tonin provide unique pathways for the generation of angiotensin II in tissue and may be of significance in regulation of biologic processes of the tissue microenvironment. The kinetic constants of the human skin chymotryptic proteinase for angiotensin I conversion, are consistent with the potential to carry out a reaction of physiologic importance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092480     DOI: 10.1111/1523-1747.ep12264144

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  25 in total

1.  Chymase cleavage of stem cell factor yields a bioactive, soluble product.

Authors:  B J Longley; L Tyrrell; Y Ma; D A Williams; R Halaban; K Langley; H S Lu; N M Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 2.  Tryptase and chymase, markers of distinct types of human mast cells.

Authors:  S S Craig; L B Schwartz
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 3.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

4.  Expression and activity levels of chymase in mast cells of burn wound tissues increase during the healing process in a hamster model.

Authors:  Xianglin Dong; Tao Xu; Shaolin Ma; Hao Wen
Journal:  Exp Ther Med       Date:  2015-04-14       Impact factor: 2.447

5.  Rapid lineage-specific diversification of the mast cell chymase locus during mammalian evolution.

Authors:  Maike Gallwitz; Lars Hellman
Journal:  Immunogenetics       Date:  2006-06-29       Impact factor: 2.846

Review 6.  Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?

Authors:  Mark C Chappell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

7.  Microwave fixation provides excellent preservation of tissue, cells and antigens for light and electron microscopy.

Authors:  G R Login; A M Dvorak
Journal:  Histochem J       Date:  1988 Jun-Jul

Review 8.  Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Authors:  Raimund Pichler; Maryam Afkarian; Brad P Dieter; Katherine R Tuttle
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-24

Review 9.  Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018).

Authors:  Sarfaraz Ahmad; Carlos M Ferrario
Journal:  Expert Opin Ther Pat       Date:  2018-10-10       Impact factor: 6.674

10.  Serine proteinases in human cutaneous mastocytosis.

Authors:  J E Fräki; N M Schechter; G S Lazarus
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.